News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Polymyxins: wisdom does not always come with age.
|Title||Polymyxins: wisdom does not always come with age.|
|Publication Type||Journal Article|
|Year of Publication||2013|
|Authors||Kassamali Z, Rotschafer JC, Jones RN, Prince RA, Danziger LH|
|Journal||Clinical infectious diseases : an official publication of the Infectious Diseases Society of America|
|Date Published||2013 Sep|
We currently face a lack of new antimicrobial therapies in an era of increasingly common multidrug-resistant (MDR) bacteria. The polymyxins have become last-line treatments for patients with MDR bacterial infections. An increasing body of published literature has attempted to answer questions about dosing, pharmacology, and susceptibility testing of these drugs, yet each takes for granted purity and potency of the 2 available polymyxin products. In the case of polymyxin B, true potency may vary by as much as 40% from the content reported in prescribing information. This poor accuracy is related to quality assurance assays established in the 1940s and currently in use, which have been shown to be significantly flawed in recent investigations. This review discusses the limitations of pharmacological knowledge about polymyxin antimicrobials, the clinical impact of these limitations, and suggestions for further study of these drugs in order to optimize their use clinically.
|Alternate Journal||Clin. Infect. Dis.|